Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 67,432 | reported | 10 Jan 2025 | tx 20+2,061,638.45−134,056.45 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jan 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 9,000 | 3.23 USD | |
| 10 Jan 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 9,000 | — | deriv |
| 03 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 1,264 | 16.72 USD | |
| 06 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 1,286 | 16.83 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 16,100 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 47,400 | 0.00 USD | deriv |
| 20 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 14,000 | 3.23 USD | |
| 20 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 14,000 | — | deriv |
| 14 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 36,050 | 3.23 USD | |
| 14 Nov 2024 | SALE | Cartesian Therapeutics, Inc. | 18,550 | 16.34 USD | |
| 15 Nov 2024 | SALE | Cartesian Therapeutics, Inc. | 16,065 | 17.06 USD | |
| 15 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 16,065 | 3.23 USD | |
| 14 Nov 2024 | SALE | Cartesian Therapeutics, Inc. | 17,500 | 17.02 USD | |
| 15 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 16,065 | — | deriv |
| 14 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 36,050 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 142,547 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 4,276.45 | — | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 778,200 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 998,000 | 0.00 USD | deriv |
| 13 Nov 2023 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 4,276.45 | — | deriv |